lercea glp 1 ampoules Melbourne doctor promoting unapproved drugs is an AI fake RACGP - Is the first

If bubbles are present, gently tap the syringe and push them out before refilling

In the SUSTAIN 8 study, patients with T2DM exhibited a lean mass decrease of 2.3 kg alongside a total weight loss of 5.3 kg, resulting in 43.4% of weight loss attributable to lean mass, while the ratio of lean mass to total mass increased by 1.2% from the baseline [111]

A taper reverses this ladder over a similar 20-to-24-week window: Weeks 1 to 4: reduce to 12.5 mg weekly Weeks 5 to 8: reduce to 10 mg weekly Weeks 9 to 12: reduce to 7.5 mg weekly Weeks 13 to 16: reduce to 5 mg weekly Weeks 17 to 20: reduce to 2.5 mg weekly Week 21: discontinue, or evaluate ongoing need at 2.5 mg The SURMOUNT-3 trial (N=579) showed that patients who completed an intensive lifestyle intervention before starting tirzepatide lost an additional 18.4% on-drug [9]

The effect is likely modest compared to pharmaceutical GLP-1 agonists, but it exists

2026 Jan 29